Immediate Impact
2 standout
Citing Papers
Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
2023 Standout
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022
2023 Standout
Works of Harsh Jogdand being referenced
Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Harsh Jogdand | 41 | 21 | 7 | 2 | 43 | ||
| Caroline Ciric | 46 | 9 | 4 | 5 | 46 | ||
| Jin-Bo Gou | 55 | 29 | 2 | 4 | 64 | ||
| Madison Ellis | 48 | 9 | 4 | 5 | 48 | ||
| Meghan K. Herring | 40 | 12 | 4 | 3 | 52 | ||
| Lauren Roper | 23 | 25 | 6 | 4 | 39 | ||
| Anita Shete-Aich | 36 | 12 | 2 | 3 | 41 | ||
| Léon Bergfeld | 51 | 11 | 6 | 4 | 58 | ||
| Amanda Kita-Yarbro | 37 | 12 | 8 | 3 | 44 | ||
| Susan L. Dobson | 35 | 4 | 10 | 4 | 52 | ||
| Christine Carr | 38 | 8 | 6 | 2 | 45 |
All Works
Loading papers...